imaware test kit

What is Prostate Cancer?

Prostate cancer is cancer that occurs in the prostate — a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.


did you know...
50% of people with cardiovascular diseases have normal cholesterol
Illustrated icon
1 in 9

Approximately 1 in 9 men will be diagnosed with prostate cancer during his lifetime

Illustrated icon
175,000

Approximately 175,000 men are diagnosed with Prostate Cancer each year

BENEFIT TO TESTING EARLY

Some Prostate Cancers are slow moving while others are aggressive, and in both scenarios identifying the cancer earlier is key. Surgery is a treatment choice for men with early-stage prostate cancer who are in good health. Surgery to remove the prostate is called prostatectomy.


recognizing the symptoms

As an man who's 40+, you should screen for prostate cancer if you have experienced any of the following symptoms:

Illustrated icon
Trouble Urinating
Illustrated icon
Decreased force in the stream of urine
Illustrated icon
Blood in Semen
Illustrated icon
Erectile Disfunction

You may have prostate cancer if a male family member has prostate cancer or a female family member has genetic markers associated with breast cancer risk(BRCA1 or BRCA2)

Illustration of a family tree
our TESTS

Our Celiac Disease Tests

Celiac Disease Screening Test

The most comprehensive at-home test for celiac disease

Celiac Disease Monitoring Test

Validate the effectiveness of your gluten-free diet

The imaware™ Cardiovascular Health Journey

Begin by establishing your baseline...

Step 1

Start your cardiovascular health journey by establishing a baseline of a broad spectrum of cardiovascular related biomarkers. This will help monitor your progress moving forward and adapt accordingly.

Cardiovascular Health Test

Our test will review your detailed cholesterol profile, inflammation and a prediabetes/diabetes screen

The imaware™ testing flow for people with diabetes or family history

First, understand if you have diabetes or prediabetes

Step 1

Baseline your risk by measuring two important measures related to diabetes. When detected earlier, people with prediabetes can stop the onset of diabetes.

Prediabetes/Diabetes Test

The only at-home test to measure both hemoglobin A1c (Hb-A1c) and fasting glucose together.

Next, identify hidden genetic risks

Step 2

40% of people have the Haptoglobin (Hp2) 2-2 gene variant, and those with diabetes are at a 500% increased risk of heart attack or stroke

Haptoglobin Genetic Test

The only at-home test to validate your haptoglobin genotype for assessing cardiovascular risk

Next, identify critical hidden risks...

Review your Genetic Risk

1 in 5 people globally have inherited high Lp(a) and most don't know they're at 2 - 4x higher risk of cardiovascular disease, yet this isn't tested in traditional cholesterol panels

Lipoprotein(a) Test

Our Lp(a) test will help determine the lipid-based cardiovascular risk for yourself and your loved ones

Understand your Inflammation Risk

50% of people with heart attacks have normal cholesterol.  Lp-PLA2 (or PLAC) is an independent risk factor and a better measure of plaque rupture than hs-CRP

Lp-PLA2 (PLAC) Test

Our PLAC test can help identify hidden inflammation risk in people over the age of 45

our TESTS

Our Wellness Tests

Men's Health & Wellness Test

Our comprehensive men's health test that reviews 16 indicators of a man's overall health

Women's Health & Wellness Test

Our comprehensive women's health test that reviews 15 indicators of a woman's overall health

our science

How Do We Accurately Test?

biomarkers and our screening method

A PSA marker, or Prostate-Specific Antigen, is a measurable indicator of the amount of protein created by cancerous and non-cancerous tissue in the prostate. We measure Total PSA, which acts as the first level of screening for Prostate Cancer


Illustration of a biomarker
Portrait of a man
Dr. Diamandis
Head of Clinical Biochemistry at Mount Sinai Hospital
medical advisory team

imaware™ tests have been validated for accuracy against existing testing methods.

We pride ourselves in creating an easy to understand report that you can feel comfortable sharing with your healthcare professional to engage them sooner.

AT-HOME MONITORING

Monitoring Celiac Disease After Diagnosis

After diagnosis, it is recommended for patients to be monitored to ensure that their lifestyle and dietary changes are in fact improving their condition.

biomarkers and our monitoring method

We utilize the same screening biomarkers to track your progression. We then plot this onto an easy to read graph so you can ensure you're heading towards healing.

engaging your health professional sooner

The results of our monitoring test should be shared with your healthcare provider to ensure that additional evaluation or testing is not required.

Tracking the reduction of celiac disease specific biomarkers over time
our mission

Working to support earlier identification

Prostate Cancer can be identified, and can be controlled to prevent further spread of the cancer. For many men, surgery is an option.

The best way to combat this condition is through early detection, allowing you to engage your doctor sooner.

Illustration of a biomarker
our PARTNERs

imaware™ works alongside the leading celiac disease organizations to help bring awareness, increase the use of convenient screening and engage in earlier diagnosis and treatment.We are also actively working on research and studies together to help find a way to potentially cure celiac disease.

why imaware™

What Makes Our Tests Different:

imaware™ is the only independently validated and scientifically peer-reviewed at-home testing platform in the United States.

Illustrated house icon

Easy & Convenient

imaware™ tests use a simple and painless process that can be completed in just a few minutes

Learn more
Illustrated biomarker icon

Fast & Accurate

Samples are tested using leading-edge Microarray equipment, and are validated by world-class doctors

Learn more
Illustrated doctor icon

World-Class Doctors

Each test is designed and validated alongside world-renowned medical doctors and scientific researchers

Learn more

Easy & Convenient

imaware™ tests use a simple and painless process that can be completed in just a few minutes

Learn more

Fast & Accurate

Samples are tested using leading-edge Microarray equipment, and are validated by world-class doctors

Learn more

World-Class Doctors

Each test is designed and validated alongside world-renowned medical doctors and scientific researchers

Learn more
We're working hard to help reduce the number of men with undiagnosed prostate cancer

How Does The Test Work?

The imaware™ home collection kit is easy to use, painless and requires only 3-5 drops of blood. Test requests are evaluated and if appropriate, authorized by a physician.

1
2
3
4
Hand pricking finger
Draw 3-5 drops of blood

Use the pain-free lancet by pressing it against the tip of your finger and press the button

Hand and collection device
Capture Sample

Capture the sample into your collection device

Illustration of a return package
Secure and return collection device

Secure the collection device, and mail it back to us with the provided return label

Illustration of a hand holding a phone
Check your results online

Within 5 days we'll send you an email link to view your results online

Want to know how the kit works before it arrives? Check out our instructional video!

Illustrated icon
PREPARING FOR A PROSTATE CANCER TEST

These are the steps to take before testing:

Icon of a grey checkmark
There is no need to fast before taking the test
Icon of a grey checkmark
You need to take this test in the morning to properly capture your hormone levels
Icon of a grey checkmark
Return your sample to the mailbox on the same day

Our other related at-home health tests

Still have questions about how imaware™ works?

Contact Us

Need more info? Email or call us:

support@imaware.health1-855-502-9273

Read our FAQs

Our Help Centre provides useful guides and answers to our most frequently asked questions

visit help center

imaware™ Blog

checkout our healthcare insights
  1. Choung RS, Larson SA, Khaleghi S, Rubio-Tapia A, Ovsyannikova IG, King KS, Larson JJ, Lahr BD, Poland GA, Camilleri MJ, Murray JA. 2017.
    Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-Based Study.
    Gastroenterology Mar;152(4):830-839. doi: 10.1053/j.gastro.2016.11.043
  2. Choung RS, Ditah IC, Nadeau AM, et al.
    Trends and racial ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012.
    Am J Gastroenterol. 2015Mar;110(3):455-61. doi: 10.1038/ajg.2015.8
  3. Wessels MMS, de Rooij N, Roovers L, Verhage J, de Vries W, Mearin ML. 2018.
    Towards an individual screening strategy for first-degree relatives of celiac patients.
    Eur J Pediatr 2018 Nov;177(11):1585-1592. doi: 10.1007/s00431-018-3199-6
  4. Hill ID. 2005.
    What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?
    Gastroenterology. 2005 Apr;128(4 Suppl 1):S25-32.
  5. Terryberry J, Tuomi J, Perampalam S, Peloquin R, Brouwer E, Schuppan D, Guandalini S
    Diagnostic accuracy of a fully automated multiplex celiac disease antibody panel for serum and plasma.
    Clin Chem Lab Med. 2019 Jul 26;57(8):1207-1217. doi: 10.1515/cclm-2019-0088.
  6. Paez MA, Gramelspacher AM, Sinacore J, Winterfield L, Venu M. 2017.
    Delay in Diagnosis of Celiac Disease in Patients Without Gastrointestinal Complaints.
    Am J Med. 2017 Nov;130(11):1318-1323. doi: 10.1016/j.amjmed.2017.05.027.